The present disclosure relates to novel metal-organic frameworks (MOFs) comprising tetratopic linkers with small pore apertures. In certain aspects, the disclosure provides Zr-MOFs, non-limiting examples include Zr(bptc), Zr(abtc), and Zr(tptc-(Me).sub.2). The present disclosure further relates to methods of utilizing the MOFs of the disclosure to separate hydrocarbons through adsorptive processes. The present disclosure further relates to the discovery that Ca(H.sub.2tcpb) metal-organic framework (MOF) is capable of separating hydrocarbon isomers from one another through adsorptive processes. In one aspect, the disclosure provides a method of separating C5-C8 hydrocarbon isomers, such that straight chain, mono-branched, and/or multi-branched isomers are each separated from one another. This separation is achieved by taking advantage of the temperature dependent adsorptive properties of Ca(H.sub.2tcpb) MOF.

The present disclosure relates to macrocyclic chelates including a macrocyclic chelating moiety of a metal complex thereof, a bifunctional linker, and a therapeutic or targeting moiety. Also disclosed are methods for preparation of the same, and use thereof.

The invention relates to a method for producing dialkylamido element compounds. In particular, the invention relates to a method for producing dialkylamido element compounds of the type E(NRR′).sub.x, wherein first WAIN is reacted with HNRR′ in order to form M[Al(NRR′).sub.4] and hydrogen, and then the formed M[Al(NRR′).sub.4] is reacted with EX.sub.x in order to form E(NRR′).sub.x and M[AlX.sub.4], wherein M=Li, Na, or K, R=C.sub.nH.sub.2n+1, where n=1 to 20, and independently thereof R′=C.sub.nH.sub.2n+1, where n=1 to 20, E is an element of the groups 3 to 15 of the periodic table of elements, X=F, Cl, Br, or I, and x=2, 3, 4 or 5.

Metal-organic framework molecules with pyrene group-containing or biphenyl group-containing linkers for use in the removal of uremic toxins from biological samples that contain such toxins are provided. Also provided are methods for using the MOFs to remove uremic toxins from biological samples. The methods include hemodialysis of blood samples from patients suffering from a uremia-related disease, such as chronic kidney failure.

Provided are an electrolytic solution for a non-aqueous secondary battery containing an electrolyte, an organic solvent, and a metal complex represented by General Formula (I), a non-aqueous secondary battery in which the electrolytic solution for a non-aqueous secondary battery is used, and a metal complex. ##STR00001## In General Formula (I), M represents a transition metal. k represents an integer of 0 or more, m represents an integer of 0 to 4, and n represents an integer of 1 or more. Here, k+n represents a valence of M. R.sup.1 represents an alkyl group, an aryl group, an alkoxy group, a carbonyl group-containing group, a sulfonyl group-containing group, or a halogen atom. R.sup.2 and R.sup.3 represent a hydrogen atom, an alkyl group, an aryl group, an alkoxy group, a carbonyl group-containing group, a sulfonyl group-containing group, or a halogen atom. L represents a monodentate ligand.

This invention relates to metal organic framework (MOF) compositions, methods of preparing them and methods of using them. The MOF compositions are characterized in that at least a portion of the linker molecule is an amino containing organic linker. The MOF also has a crystal size of greater than 1 μm and has been treated with an acid wash to provide a MOF in which at least 55% of the amino groups are activated amino groups of the form —NH.sub.2. The MOF compositions are useful in adsorbing various contaminants from various gas stream. One specific example is adsorbing NO.sub.2 from an air stream.

The invention provides a method of preparing a .sup.89Zr-oxine complex of the formula ##STR00001##
The invention also provides a method of labeling a cell with the .sup.89Zr-oxine complex and a method for detecting a biological cell in a subject comprising administering the .sup.89Zr-oxine complex to the subject.

A perovskite material including an organic-inorganic perovskite structure of formula (I), A.sub.nMX.sub.3 (I), n being the number of cation A and an integer >4, A being a monovalent cation selected from inorganic cations Ai and/or from organic cations Ao, M being a divalent metal cation or a combination thereof, X being a halide and/or pseudohalide anion or a combination thereof, wherein at least one cation A is selected from organic cations Ao, the inorganic cations Ai are independently selected from Li.sup.+, Na.sup.+, K.sup.+, Rb.sup.+, Cs.sup.+, or Tl.sup.+ and the organic cations Ao are independently selected from ammonium (NH.sub.4.sup.+), methyl ammonium (MA) (CH.sub.3NH.sub.3.sup.+), ethyl ammonium (CH.sub.3CH.sub.2NH.sub.3).sup.+, formamidinium (FA) (CH(NH.sub.2).sub.2.sup.+), methylformamidinium (CH.sub.3C(NH.sub.2).sub.2.sup.+), guanidium (C((NH).sub.2).sub.3.sup.+), tetramethylammonium ((CH.sub.3).sub.4N.sup.+), dimethylammonium ((CH.sub.3).sub.2NH.sub.2.sup.+) or trimethylammonium ((CH.sub.3).sub.3NH.sup.+).

A composition includes: a metal compound including a ligand; and a solvent. The ligand is derived from a compound represented by formula (1). L represents an oxygen atom or a single bond; R.sup.1 represents a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms; R.sup.2 and R.sup.3 each independently represent a hydrogen atom or a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, or R.sup.2 and R.sup.3 bind with each other and represent an alicyclic structure having 3 to 20 ring atoms together with the carbon atom to which R.sup.2 and R.sup.3 bond, or le and either R.sup.2 or R.sup.3 bind with each other and represent a lactone ring structure having 4 to 20 ring atoms or a cyclic ketone structure having 4 to 20 ring atoms together with the atom chain to which le and either R.sup.2 or R.sup.3 bond.

##STR00001##

The present invention relates to low temperature process for preparing nanoparticles of porous crystalline Fe-, Al- or Ti-based MOF carboxylate materials with low polydispersity index, and uses thereof, particularly as catalyst support for carrying out heterogeneously catalyzed chemical reactions, or as gas storage/separation/purification material, or as matrix for encapsulating active principles (medicine, cosmetics).